Portilho Amanda Izeli, Trzewikoswki de Lima Gabriela, De Gaspari Elizabeth
Departament of Immunology, Adolfo Lutz Institute, São Paulo, Brazil Post-Graduate Program Interunity in Biotechnology, Biomedical Sciences Institute, São Paulo University, São Paulo, Brazil.
Departament of Immunology, Adolfo Lutz Institute, Dr Arnaldo Avenue 355, 11 floor, São Paulo, SP 01246-902, Brazil.
Ther Adv Vaccines Immunother. 2020 May 8;8:2515135520919195. doi: 10.1177/2515135520919195. eCollection 2020.
is the main cause of bacterial meningitis in Brazil, where the main serogroups isolated are B and C; however, the serogroup W has recently emerged. LPS and type IV pili are important virulence factors that increase meningococci pathogenicity.
The characterization of Lipopolysaccharide (LPS) and type IV pili in 19 meningococci strains of serogroup B, 21 of serogroup C, 45 of serogroup W and 28 of serogroup Y, isolated in Brazil between 2011 and 2017, was conducted using the Enzyme-linked Immunosorbent Assay (Dot- ELISA) technique and monoclonal antibodies.
We would like to emphasize the importance of characterizing relevant antigens, such as pili and LPS, the use of monoclonal antibodies to support it, and how such studies improve vaccine development and monitoring. Most of the strains studied presented L3,7,9 LPS and type IV pili; both antigens are associated with the capacity to cause invasive disease.
Due to the impact of meningococcal disease, it is important to maintain and improve vaccine studies. Epitopes characterization provides data about the virulence of circulating strains. The use of monoclonal antibodies and serological techniques are relevant and support vaccine development.
在巴西,是细菌性脑膜炎的主要病因,分离出的主要血清群为B群和C群;然而,血清群W最近出现了。脂多糖(LPS)和IV型菌毛是增加脑膜炎球菌致病性的重要毒力因子。
采用酶联免疫吸附测定(Dot-ELISA)技术和单克隆抗体,对2011年至2017年在巴西分离的19株B群脑膜炎球菌、21株C群脑膜炎球菌、45株W群脑膜炎球菌和28株Y群脑膜炎球菌的脂多糖(LPS)和IV型菌毛进行了鉴定。
我们想强调鉴定相关抗原(如菌毛和LPS)的重要性,使用单克隆抗体来支持这一鉴定,以及此类研究如何改进疫苗开发和监测。大多数研究菌株呈现L3,7,9 LPS和IV型菌毛;这两种抗原都与引起侵袭性疾病的能力有关。
由于脑膜炎球菌病的影响,维持和改进疫苗研究很重要。表位鉴定提供了有关流行菌株毒力的数据。单克隆抗体和血清学技术的使用是相关的,并支持疫苗开发。